nnc 112 and raclopride
nnc 112 has been researched along with raclopride in 3 studies
Compound Research Comparison
| Studies (nnc 112) | Trials (nnc 112) | Recent Studies (post-2010) (nnc 112) | Studies (raclopride) | Trials (raclopride) | Recent Studies (post-2010) (raclopride) |
|---|---|---|---|---|---|
| 32 | 3 | 7 | 1,802 | 132 | 419 |
Protein Interaction Comparison
| Protein | Taxonomy | nnc 112 (IC50) | raclopride (IC50) |
|---|---|---|---|
| D(2) dopamine receptor | Homo sapiens (human) | 0.052 | |
| D(2) dopamine receptor | Mus musculus (house mouse) | 0.032 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0279 |
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Gerlach, J; Jensen, G; Nicholson, K; Peacock, L | 1 |
| Cumming, P; Doudet, DJ; Rosa-Neto, P | 1 |
| Alexoff, D; Carter, P; Fowler, JS; Kang, Y; Kim, D; Kim, SW; King, P; Logan, J; Muench, L; Shea, C; Skolnick, P; Volkow, ND | 1 |
Other Studies
3 other study(ies) available for nnc 112 and raclopride
| Article | Year |
|---|---|
Extrapyramidal side effects during chronic combined dopamine D1 and D2 antagonist treatment in Cebus apella monkeys.
Topics: Animals; Basal Ganglia Diseases; Benzazepines; Benzofurans; Cebus; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Male; Raclopride; Receptors, Dopamine D1; Time Factors | 1999 |
Gradients of dopamine D1- and D2/3-binding sites in the basal ganglia of pig and monkey measured by PET.
Topics: Animals; Benzazepines; Benzofurans; Binding Sites; Brain Mapping; Carbon Isotopes; Corpus Striatum; Dopamine Antagonists; Macaca mulatta; Male; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Swine; Swine, Miniature; Tissue Distribution; Tomography, Emission-Computed | 2004 |
Therapeutic doses of buspirone block D3 receptors in the living primate brain.
Topics: Administration, Oral; Animals; Anti-Anxiety Agents; Benzazepines; Benzofurans; Buspirone; Corpus Striatum; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Female; Functional Neuroimaging; Globus Pallidus; Injections, Intramuscular; Mesencephalon; Oxazines; Papio anubis; Positron-Emission Tomography; Raclopride; Radioligand Assay; Receptors, Dopamine D3 | 2014 |